Today: 17 May 2026
MongoDB stock dives on weak outlook and sales shake-up — what MDB investors watch next
3 March 2026
2 mins read

MongoDB stock dives on weak outlook and sales shake-up — what MDB investors watch next

New York, March 3, 2026, 11:28 EST — Regular session

  • MongoDB plunged roughly 22% in early trading, tumbling to an intraday low close to $229.61.
  • Database software maker put out a first-quarter adjusted profit outlook that fell short of investor expectations.
  • Baird dropped its rating to neutral, pointing to Atlas growth concerns and execution risk as new leadership steps in.

MongoDB plunged 21.7% to $254.64 on Tuesday, deepening its slide after a wary first-quarter forecast and word of leadership shifts in its go-to-market team. Volume spiked—roughly 6.5 million shares had traded by late morning.

MongoDB’s decline is drawing attention, with investors using the name as a kind of touchstone for cloud and software demand. For stocks trading on a steady-growth story, even a mild guidance cut can sting more than a strong quarter might help.

Atlas is right in the thick of the debate. MongoDB’s cloud database service runs on a consumption model: customers pay for what they use. If workloads dip or companies tighten spending, growth can slow down in a hurry.

MongoDB posted fourth-quarter revenue of $695.1 million late Monday, a 27% jump from the prior year. The company said it gained 2,700 new customers, pushing its total above 65,200 as of Jan. 31. Looking ahead, MongoDB projected first-quarter revenue in the $659 million to $664 million range and adjusted earnings per share between $1.15 and $1.19, with the usual carve-outs for items like stock-based pay. Full-year guidance landed at $2.86 billion to $2.90 billion in revenue, and adjusted EPS of $5.75 to $5.93. CEO CJ Desai described the results as “achieving a rule of 40 performance,” the investor shorthand for a combined growth rate and profit margin adding up to about 40. PR Newswire

Chief Financial Officer Mike Berry told analysts on the earnings call that MongoDB is looking for Atlas revenue to climb roughly 26% in the first quarter, while projecting a 21%-23% gain for fiscal 2027. “We are a consumption business and visibility is more limited in the back half,” Berry said. Investing.com

Baird cut its rating on MongoDB to neutral Tuesday, flagging uncertainties over Atlas growth, scant near-term AI revenue, and shifts in management that could drag on the stock. The broker also pointed to possible renewed competition from Postgres—the open-source database engine—highlighting challenges from private Databricks and Snowflake-backed products. Leadership turnover, Baird said, brings fresh risks to go-to-market strategy. The firm noted remaining performance obligations jumped 97% to $1.47 billion.

The drop in MongoDB shares came during a tough session for risk assets. U.S. equities sold off across the board, with oil spiking and investors rattled by fresh inflation fears tied to the escalating U.S.-Iran tensions, according to Reuters.

Still, there’s a clear risk here: should Atlas growth slow beyond what management has penciled in, revenue could falter fast and shares might get knocked down. A disorganized sales transition would only add to the trouble.

Traders have trimmed their near-term focus to a few items. They’re looking for proof that Atlas consumption is holding up, plus a smooth handoff inside the sales team as MongoDB ramps up its rollout of AI features—think vector search and embeddings.

Investors now turn to the next key event: the earnings report, scheduled for May 28, according to Investing.com. All eyes are on whether Atlas’s growth story can deliver evidence of momentum.

Stock Market Today

  • FirstEnergy Valuation Under Review Amid Conflicting Fair Value Estimates
    May 16, 2026, 10:33 PM EDT. FirstEnergy (FE) shares fell 12.5% over 30 days to $43.82, prompting investor scrutiny. The utility, valued at $25.3 billion, benefits from a $28 billion infrastructure modernization plan aimed at boosting reliability and earnings. Analysts see potential undervaluation with a fair value near $53.23, reflecting expected growth. However, a discounted cash flow (DCF) model suggests a more conservative fair value of $28.75, highlighting concerns over cash flow and funding risks. This divergence marks a critical juncture for investors weighing regulatory impacts and capital needs against growth prospects in the power transmission sector.

Latest articles

Joby Aviation Slides Monday With Air-Taxi in Focus

Joby Aviation Slides Monday With Air-Taxi in Focus

17 May 2026
Joby Aviation shares closed Friday at $10.36, down 2.6% for the day and 4.7% for the week. CEO JoeBen Bevirt-linked trusts sold over 421,000 shares under a preset 10b5-1 plan, filings showed. The stock traded between $10.04 and $10.58 during a volatile week. Broader markets and eVTOL sector peers also declined.
ImmunityBio’s BCG Agreement Puts Monday’s Trading in Focus

ImmunityBio’s BCG Agreement Puts Monday’s Trading in Focus

17 May 2026
ImmunityBio closed at $7.97 Friday, down 2.2% after announcing exclusive U.S. rights to Japan BCG Laboratory’s Tokyo-172 strain for bladder cancer therapy. The Tokyo strain remains investigational in the U.S. and is not FDA-approved. Nasdaq was closed for the weekend; the next trading session is Monday. ImmunityBio’s Q1 product revenue rose to $44.2 million with $380.9 million in cash and securities.
Infleqtion Stock Just Took a Hit After Record Revenue — What Could Move INFQ Next

Infleqtion Stock Just Took a Hit After Record Revenue — What Could Move INFQ Next

17 May 2026
Infleqtion Inc. shares fell 10.95% to $12.44 Friday, capping a rough week for quantum tech stocks. The company reported a first-quarter net loss of $30.3 million on $9.5 million in revenue, with 85% from government contracts. Infleqtion launched a new RF sensing platform and raised its 2026 revenue outlook, but warned of continued operating losses.
Synopsys Shares Dropped for the Week, Looking to May 27 for Direction

Synopsys Shares Dropped for the Week, Looking to May 27 for Direction

17 May 2026
Synopsys shares fell 1.49% Friday to $502.42, ending the week down 2.72% amid a broad tech selloff and news that Coatue Management cut its stake by 54%. The Nasdaq Composite dropped 1.54% Friday, while the Philadelphia semiconductor index slid 4%. Synopsys will report fiscal Q2 results after the market closes on May 27. Wells Fargo and Citigroup raised their price targets for the stock earlier in the week.
Silver plunges as Iran war boosts dollar and delays Fed cuts — SLV back in focus
Previous Story

Silver plunges as Iran war boosts dollar and delays Fed cuts — SLV back in focus

Occidental Petroleum stock price whipsaws as oil jumps on Iran conflict; OXY traders eye March 4 deadline
Next Story

Occidental Petroleum stock price whipsaws as oil jumps on Iran conflict; OXY traders eye March 4 deadline

Go toTop